Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Biologics Development and Compliance

Published:

Thermo Fisher Scientific today launched a new collection of qPCR biopharma offerings to help accelerate drug development to meet a growing demand for novel biologics. The QualTrak comprehensive suite of qPCR tools is comprised of a premium selection of trusted Applied Biosystems solutions, including QuantStudio 6 and 7 Pro Real-Time PCR Systems* and TaqMan and TaqPath master mixes and assays, to consistently and accurately support the biopharma industry from discovery to post-approval manufacturing. “PCR-based technologies play an integral role across all phases of drug development, and biopharmaceutical developers and manufacturers need reliable tools to help them avoid wasting precious time and resources repeating and revalidating steps,” said Santhosh Nair, vice president and general manager of qPCR at Thermo Fisher Scientific.

Read more about this news here.

Related articles

Recent articles